Telix Pharmaceuticals Limited - American Depositary Shares (TLX) analyst actions
Rating and price-target actions on TLX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the TLX overview →
3 measured TLX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded | Press release | -0.70% | +0.70% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Telix Pharmaceuticals Limited (TLX) And Encourages Shareholders to Reach Out | Press release | — | +0.51% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Telix Pharmaceuticals Limited (TLX) And Encourages Stockholders to Reach Out | Press release | — | +1.20% |
Keep exploring
More TLX: earnings → · SEC filings → · TLX overview →